Bill Texts: NJ A2488 | 2020-2021 | Regular Session

Bill Title: Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

Spectrum: Moderate Partisan Bill (Democrat 4-1)

Status: (Introduced - Dead) 2020-02-03 - Introduced, Referred to Assembly Health Committee [A2488 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2020-02-03HTML/TextLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for New Jersey A2488

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for New Jersey A2488 currently on file.

Social Comments on NJ A2488

feedback